ELOCON (mometasone furoate) Cream, 0.1%, Schering NDA 19-625/S-012 & S-013 7/17/02 7/24/02 7/19/02 ELOCON (mometasone furoate) Lotion, 0.1%, Schering NDA 19-796/S-08 & S-015 7/17/02 7/24/02 7/19/02 ELOCON (mometasone furoate) Ointment, 0.1%, Schering NDA 19-543/S-014 12/15/02 1/23/03 12/16/02 ELOCON (mometasone furoate) Ointment, 0.1%, Schering NDA 19-543/S-011 & S-013 Mometasone Furoate Cream USP, 0.1%, Altana ANDA 76-171 7/10/02 Mometasone Furoate Ointment USP, 0.1%, Clay-Park Labs, ANDA 76-067 3/18/02 4/10/03 Mometasone Furoate Ointment USP, 0.1%, Clay-Park Labs, ANDA 76-067 2/1/02 Mometasone Furoate Topical Solution USP, 0.1%, Altana ANDA 75-919 Nasonex (Mometasone Furoate Monohydrate) Aqueous Nasal Spray, Schering Corp. NDA 20-762/S-014 3/3/03 3/10/03 Nasonex Nasal Spray, 50 mcg., Schering Corp. NDA 20-762/S-001 11/19/98 1/12/99 5/25/01 Nasonex Indication: Prophylaxis and treatment of the nasal symptoms of seasonal allergic rhinitis and the treatment of the nasal symptoms of perennial allergic rhinitis, in adults and children 12 years of age and older. Mometasone Furoate Ointment USP, Atrix Mometasone Furoate Topical Solution, Atrix Laboratories, Nasonex (Mometasone Furoate Monohydrate) Aqueous Nasal Spray, Schering Corp. Mometasone Furoate Cream USP, Atrix Laboratories, Inc., Nasonex (mometasone furoate monohydrate) Aqueous Nasal Spray, Schering Corp., Formulation Revision | Mometasone Furoate Cream, Taro Pharmaceuticals, Tentative Approval |Mometasone Furoate Ointment, Taro Pharmaceuticals, Approval | Mometasone Furoate Topical Solution, Taro Pharmaceuticals, Tentative Approval | Mometasone Furoate Ointment, Altana Inc., Approval 077061 | Asmanex Twisthaler (mometasone furoate) inhalation powder, Schering Corp., Approval | Mometasone Furate Topical Solution, Agis, Approval | Mometasone Furoate Cream, Altana Inc., Approval

For the most up-to-date approval information, please locate this API using the drug index.